Biomark Diagnostics Inc (BUX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -5 | 8 | -2 | 27 | -9 |
| Other Working Capital | 221 | 28 | 22 | 188 | 120 |
| Other Operating Activity | -106 | -158 | -205 | -681 | -242 |
| Operating Cash Flow | $109 | $-122 | $-186 | $-466 | $-131 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 0 | 164 | 239 | 0 |
| Other Financing Activity | -115 | 126 | 11 | 238 | 114 |
| Financing Cash Flow | $-115 | $126 | $175 | $477 | $114 |
| Beginning Cash Position | 8 | 4 | 14 | 4 | 21 |
| End Cash Position | 2 | 8 | 4 | 14 | 4 |
| Net Cash Flow | $-6 | $4 | $-10 | $10 | $-17 |
| Free Cash Flow | |||||
| Operating Cash Flow | 109 | -122 | -186 | -466 | -131 |
| Free Cash Flow | 109 | -122 | -186 | -466 | -131 |